![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SLCO4A1 |
Gene summary for SLCO4A1 |
![]() |
Gene information | Species | Human | Gene symbol | SLCO4A1 | Gene ID | 28231 |
Gene name | solute carrier organic anion transporter family member 4A1 | |
Gene Alias | OATP-E | |
Cytomap | 20q13.33 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q96BD0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
28231 | SLCO4A1 | HTA11_1391_2000001011 | Human | Colorectum | AD | 5.37e-05 | 2.39e-01 | -0.059 |
28231 | SLCO4A1 | HTA11_866_3004761011 | Human | Colorectum | AD | 5.58e-04 | 2.36e-01 | 0.096 |
28231 | SLCO4A1 | HTA11_7696_3000711011 | Human | Colorectum | AD | 2.19e-05 | 2.26e-01 | 0.0674 |
28231 | SLCO4A1 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 1.24e-05 | 2.52e-01 | 0.294 |
28231 | SLCO4A1 | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 4.79e-02 | 5.33e-01 | 0.3487 |
28231 | SLCO4A1 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 4.73e-34 | 8.65e-01 | 0.3859 |
28231 | SLCO4A1 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 5.06e-07 | 6.28e-01 | 0.2585 |
28231 | SLCO4A1 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 4.14e-02 | 1.61e-01 | 0.3005 |
28231 | SLCO4A1 | LZE6T | Human | Esophagus | ESCC | 5.38e-03 | 2.26e-01 | 0.0845 |
28231 | SLCO4A1 | P5T-E | Human | Esophagus | ESCC | 1.46e-03 | 7.31e-02 | 0.1327 |
28231 | SLCO4A1 | P21T-E | Human | Esophagus | ESCC | 5.19e-25 | 6.43e-01 | 0.1617 |
28231 | SLCO4A1 | P23T-E | Human | Esophagus | ESCC | 4.84e-02 | 3.41e-01 | 0.108 |
28231 | SLCO4A1 | P26T-E | Human | Esophagus | ESCC | 7.35e-05 | 3.64e-02 | 0.1276 |
28231 | SLCO4A1 | P28T-E | Human | Esophagus | ESCC | 1.99e-09 | 1.76e-01 | 0.1149 |
28231 | SLCO4A1 | P37T-E | Human | Esophagus | ESCC | 1.44e-02 | 1.29e-01 | 0.1371 |
28231 | SLCO4A1 | P39T-E | Human | Esophagus | ESCC | 3.95e-02 | 1.43e-01 | 0.0894 |
28231 | SLCO4A1 | P62T-E | Human | Esophagus | ESCC | 2.55e-06 | 5.11e-01 | 0.1302 |
28231 | SLCO4A1 | P74T-E | Human | Esophagus | ESCC | 3.69e-02 | 9.91e-02 | 0.1479 |
28231 | SLCO4A1 | P75T-E | Human | Esophagus | ESCC | 1.06e-05 | 1.68e-01 | 0.1125 |
28231 | SLCO4A1 | P76T-E | Human | Esophagus | ESCC | 1.65e-06 | 2.23e-01 | 0.1207 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SLCO4A1 | SNV | Missense_Mutation | novel | c.836N>A | p.Gly279Asp | p.G279D | Q96BD0 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-SJ-A6ZI-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SLCO4A1 | insertion | Frame_Shift_Ins | novel | c.1008_1009insG | p.Ser338LeufsTer215 | p.S338Lfs*215 | Q96BD0 | protein_coding | TCGA-AP-A0LH-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | PD | ||
SLCO4A1 | deletion | Frame_Shift_Del | c.1753_1756delNNNN | p.Phe585LeufsTer2 | p.F585Lfs*2 | Q96BD0 | protein_coding | TCGA-D1-A17B-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
SLCO4A1 | deletion | Frame_Shift_Del | novel | c.101delN | p.Pro35ArgfsTer5 | p.P35Rfs*5 | Q96BD0 | protein_coding | TCGA-EY-A1GK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
SLCO4A1 | SNV | Missense_Mutation | novel | c.995N>G | p.Pro332Arg | p.P332R | Q96BD0 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-CC-A7IG-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | PD |
SLCO4A1 | SNV | Missense_Mutation | novel | c.1565N>G | p.Asp522Gly | p.D522G | Q96BD0 | protein_coding | deleterious(0.04) | benign(0.12) | TCGA-50-6591-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
SLCO4A1 | SNV | Missense_Mutation | rs759260457 | c.1566N>A | p.Asp522Glu | p.D522E | Q96BD0 | protein_coding | deleterious(0.03) | benign(0.203) | TCGA-55-6987-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
SLCO4A1 | SNV | Missense_Mutation | novel | c.1068N>A | p.Ser356Arg | p.S356R | Q96BD0 | protein_coding | tolerated(0.09) | benign(0.005) | TCGA-55-7994-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | carboplatin | CR |
SLCO4A1 | SNV | Missense_Mutation | novel | c.628N>A | p.Ala210Thr | p.A210T | Q96BD0 | protein_coding | tolerated(0.34) | benign(0.015) | TCGA-55-8506-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SLCO4A1 | SNV | Missense_Mutation | c.965T>C | p.Phe322Ser | p.F322S | Q96BD0 | protein_coding | deleterious(0.03) | benign(0.054) | TCGA-55-A492-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
28231 | SLCO4A1 | DRUGGABLE GENOME, TRANSPORTER | 178101458 |
Page: 1 |